Alaunos Therapeutics annual operating margin
2011
2012
2016
2017
2018
2021
2022
2023
2024
2025
Alaunos Therapeutics Operating Margin Growth & History (TCRT)
Alaunos Therapeutics's operating margin was −84,500.00% for fiscal 2025.
View full Alaunos Therapeutics company overviewAlaunos Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −84,500.00% | −36380.00 pp |
| 2024 | 2024-12-31 | −48,120.00% | +637220.00 pp |
| 2023 | 2023-12-31 | −685,340.00% | −684138.60 pp |
| 2022 | 2022-12-31 | −1,201.40% | +18283.27 pp |
| 2021 | 2021-12-31 | −19,484.67% | +17437.24 pp |
| 2018 | 2018-12-31 | −36,921.92% | −36084.65 pp |
| 2017 | 2017-12-31 | −837.27% | +1572.10 pp |
| 2016 | 2016-12-31 | −2,409.37% | +10361.75 pp |
| 2012 | 2012-12-31 | −12,771.13% | −2066.48 pp |
| 2011 | 2011-12-31 | −10,704.65% | — |
Alaunos Therapeutics quarterly operating margin
Q1.11
Q1.12
Q2.17
Q3.17
Q1.18
Q3.21
Q3.22
Q2.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q4.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −30,233.33% | +143966.67 pp |
| Q1 2025 | 2025-03-31 | −54,600.00% | +740300.00 pp |
| Q4 2024 | 2024-12-31 | −15,080.00% | +184470.00 pp |
| Q2 2024 | 2024-06-30 | −29,150.00% | −28866.11 pp |
| Q1 2024 | 2024-03-31 | −174,200.00% | −168597.99 pp |
| Q4 2023 | 2023-12-31 | −794,900.00% | −783806.85 pp |
| Q2 2023 | 2023-06-30 | −199,550.00% | −198731.60 pp |
| Q3 2022 | 2022-09-30 | −283.89% | +531.01 pp |
| Q3 2021 | 2021-09-30 | −5,602.01% | +3714.49 pp |
| Q1 2018 | 2018-03-31 | −11,093.15% | +30587.45 pp |
| Q3 2017 | 2017-09-30 | −818.40% | — |
| Q2 2017 | 2017-06-30 | −814.90% | — |
| Q1 2012 | 2012-03-31 | −9,316.50% | — |
| Q1 2011 | 2011-03-31 | −41,680.60% | — |
Alaunos Therapeutics operating margin trends
Over the last five reported fiscal years, Alaunos Therapeutics's operating margin decreased from −36,921.92% to −84,500.00%, a change of −47578.08 percentage points. The latest reported quarter, Q4 2025, shows −30,233.33%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alaunos Therapeutics filings at SEC.gov ↗